top of page

Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients

About the study

NCT Trial Number

NCT04141501

The drug being studied

Psilocybin

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

University of Zurich
Schweizerischer Nationalfonds

noun_date_3237048.png

Trial Start Date

Jun-20

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 60 Years

gender

Female

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Alcohol Use Disorder

noun_square_138133.png

Accepts healthy volunteers?

No

This study will explore the use of psilocybin on alcohol consumption on alcohol addicted patients who have undergone withdrawal treatments.

Eyes Graffiti

Locations

Switzerland
Psychiatrische Universitätsklinik Zürich
Zürich, Switzerland, 8032

Contact: Nathalie Rieser
+41 44 384 33 24
nathalie.rieser@bli.uzh.ch

Contact: Katrin Preller, Phd
+41 44 384 25 26
preller@bli.uzh.ch

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page